WallStSmart

MercadoLibre Inc. (MELI)vsNextTrip Inc (NTRP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MercadoLibre Inc. generates 632368% more annual revenue ($31.80B vs $5.03M). MELI leads profitability with a 6.0% profit margin vs -290.0%. MELI earns a higher WallStSmart Score of 58/100 (C).

MELI

Buy

58

out of 100

Grade: C

Growth: 7.3Profit: 6.5Value: 6.7Quality: 4.0
Piotroski: 2/9Altman Z: 1.35

NTRP

Avoid

23

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 6.7Quality: 3.5
Piotroski: 3/9Altman Z: -8.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MELIUndervalued (+61.3%)

Margin of Safety

+61.3%

Fair Value

$5220.85

Current Price

$1863.31

$3357.54 discount

UndervaluedFair: $5220.85Overvalued
NTRPUndervalued (+80.5%)

Margin of Safety

+80.5%

Fair Value

$16.12

Current Price

$1.65

$14.48 discount

UndervaluedFair: $16.12Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MELI4 strengths · Avg: 9.0/10
Revenue GrowthGrowth
49.0%10/10

Revenue surging 49.0% year-over-year

Market CapQuality
$91.21B9/10

Large-cap with strong market position

Return on EquityProfitability
26.4%9/10

Every $100 of equity generates 26 in profit

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

NTRP1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
946.0%10/10

Revenue surging 946.0% year-over-year

Areas to Watch

MELI4 concerns · Avg: 3.3/10
Price/BookValuation
13.0x4/10

Trading at 13.0x book value

Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Debt/EquityHealth
1.703/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

NTRP4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$24.31M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-681.0%2/10

ROE of -681.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : MELI

The strongest argument for MELI centers on Revenue Growth, Market Cap, Return on Equity. Revenue growth of 49.0% demonstrates continued momentum. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : NTRP

The strongest argument for NTRP centers on Revenue Growth. Revenue growth of 946.0% demonstrates continued momentum.

Bear Case : MELI

The primary concerns for MELI are Price/Book, Profit Margin, Debt/Equity. A P/E of 48.1x leaves little room for execution misses. Debt-to-equity of 1.70 is elevated, increasing financial risk.

Bear Case : NTRP

The primary concerns for NTRP are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

NTRP carries more volatility with a beta of 1.59 — expect wider price swings.

NTRP is growing revenue faster at 946.0% — sustainability is the question.

MELI generates stronger free cash flow (1.3B), providing more financial flexibility.

Monitor INTERNET RETAIL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MELI scores higher overall (58/100 vs 23/100) and 49.0% revenue growth. NTRP offers better value entry with a 80.5% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MercadoLibre Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · USA

MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.

NextTrip Inc

CONSUMER CYCLICAL · TRAVEL SERVICES · USA

Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?